Precision Medicine for Ocular Diseases

Studying and deciphering vision-related diseases is complicated by the delicate structure of the eye itself. While biopsies and samples from many other bodily systems are relatively easily obtained by physicians, collecting the vitreous fluid from within the eye is a more challenging task and often fails. The lack of a standardized process to collect and…

Laboratory research paves the way for a clinical trial to see if an FDA-approved drug used to prevent organ transplant rejection can work against these aggressive brain tumors.

Funding from the Taubman Institute has helped a team of researchers develop a new approach to treating aggressive brain tumors. Daniel Wahl, MD, PhD, a radiation oncologist and researcher at Michigan Medicine, says an existing drug used to prevent organ transplant rejection may make radiation therapy more effective for glioblastoma patients by targeting a critical…

Taubman Institute funds early-detection COVID study that uses wearable devices

Early in the wake of the pandemic as new epidemiological data were emerging, a major concern shared by healthcare workers (HCWs) was the potential to transmit virus without any warning signs. A critical unaddressed issue is whether early detection, especially of infection before obvious symptoms, can prevent “pre-symptomatic transmission” and stop further spread.   Sung…

Taubman Emerging Scholar Sheds Light on Possible Suicide Risk of Covid-19 Front Line Caretakers

Srijan Sen, MD, PhD, Associate Professor, Psychiatry, Associate Vice President for Health Sciences, and Frances and Kenneth Eisenberg Professor of Depression and Neurosciences, is one of five mental health care providers and advocates who discuss elevated suicide risk in the most recent issue of BridgeMI.com. In the article, Dr. Sen says, “There is this issue…